Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.84 EUR Market Closed
Market Cap: 55m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Relative Value

The Relative Value of one SHE stock under the Base Case scenario is 8 EUR. Compared to the current market price of 4.84 EUR, Shedir Pharma Srl Unipersonale is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHE Relative Value
Base Case
8 EUR
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
77
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
0.9
vs History
76
vs Industry
39
Median 3Y
8.9
Median 5Y
10
Industry
23
Forward
8.7
vs History
12
vs Industry
4
Median 3Y
20.8
Median 5Y
5.4
Industry
17.8
vs History
vs Industry
17
Median 3Y
-9.2
Median 5Y
-8.9
Industry
25.4
vs History
76
vs Industry
51
Median 3Y
1.5
Median 5Y
1.6
Industry
2.2
vs History
41
vs Industry
81
Median 3Y
0.8
Median 5Y
0.8
Industry
2.8
Forward
0.9
vs History
39
vs Industry
81
Median 3Y
1.3
Median 5Y
1.4
Industry
5.4
vs History
46
vs Industry
48
Median 3Y
3.8
Median 5Y
3.9
Industry
13.7
Forward
4.4
vs History
41
vs Industry
44
Median 3Y
5.5
Median 5Y
5.7
Industry
17.2
Forward
6.4
vs History
12
vs Industry
4
Median 3Y
17.1
Median 5Y
4.9
Industry
16.5
vs History
vs Industry
22
Median 3Y
2.6
Median 5Y
2.8
Industry
19.3
vs History
71
vs Industry
53
Median 3Y
1.3
Median 5Y
1.3
Industry
2

Multiples Across Competitors

SHE Competitors Multiples
Shedir Pharma Srl Unipersonale Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
55m EUR 0.9 9.6 4.7 6.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
Average P/E: 30.3
9.6
29%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top